BOTTOM LINE: The NASDAQ Biotech Index has been in a trading range for 10 months. My short-term trading indicators generated buy signals on this index early last week. It proceeded to break through the 800 resistance level on Thursday, with a confirmation of the break on Friday. Partnerships with major pharmaceutical companies, FDA approvals and low interests rates should propel this sector higher in the intermediate-term.
Portfolio Manager's Commentary on Investing and Trading in the U.S. Financial Markets
Sunday, March 07, 2004
Chart of the Week
NASDAQ Biotechnology Index 1-Year Candlestick Chart
BOTTOM LINE: The NASDAQ Biotech Index has been in a trading range for 10 months. My short-term trading indicators generated buy signals on this index early last week. It proceeded to break through the 800 resistance level on Thursday, with a confirmation of the break on Friday. Partnerships with major pharmaceutical companies, FDA approvals and low interests rates should propel this sector higher in the intermediate-term.
BOTTOM LINE: The NASDAQ Biotech Index has been in a trading range for 10 months. My short-term trading indicators generated buy signals on this index early last week. It proceeded to break through the 800 resistance level on Thursday, with a confirmation of the break on Friday. Partnerships with major pharmaceutical companies, FDA approvals and low interests rates should propel this sector higher in the intermediate-term.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment